Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Vitamin D supplementation aimed at reducing IVIG resistance or coronary artery lesions remains investigational and should not be used routinely until multi-center prospective trials with hard clinical endpoints confirm its benefit.
Source: Original paper. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Publisher article type: review-article
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D and Kawasaki disease
Review / evidence synthesis · Frontiers in Pharmacology · 2026
Original publication title
Vitamin D and Kawasaki disease
Copyright © 2026 Yang and Zeng.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Vitamin D deficiency has been widely reported worldwide. Vitamin D is essential for mineral homeostasis and skeletal health, and is also associated with numerous extra-skeletal diseases, including cancer, autoimmune diseases, psychosis, allergies and cardiovascular disease. Recent evidence suggests that vitamin D deficiency might be a risk factor for immunoglobulin resistance in Kawasaki disease (KD), and that levels of 25-hydroxyvitamin D3 (25(OH)D3) could predict the risk of coronary artery disease in KD patients. These findings have sparked growing interest in exploring the mechanistic and clinical links between vitamin D and KD pathogenesis.
However, the relationship between vitamin D levels and KD remains incompletely understood, warranting further comprehensive investigation.
Source: BackgroundAbstract: Mechanisms and evidence reviewed
Previous studies found that proinflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-6, are elevated during the acute phase of KD and are associated with activation of vascular endothelial cells, which can lead to varying degrees of vascular wall inflammation. Vitamin D, a multifunctional prohormone with well-documented anti-inflammatory properties, may exert protective effects in KD by enhancing endothelial function, reducing coronary artery damage risk, and inhibiting platelet activity to alleviate fibrinolysis, thrombosis, and inflammation.
Source: Mechanisms and evidence reviewedAbstract: Conclusions
This study updates the current understanding of the association between serum vitamin D levels and KD, explores potential regulatory mechanisms underlying this relationship, and identifies critical knowledge gaps to guide future cohort studies and clinical trials in KD research. Early clinical data indicate that adjunctive vitamin D may modulate inflammatory responses in acute KD, but whether supplementation reduces intravenous immunoglobulin (IVIG) resistance or prevents coronary artery lesions remains unproven and requires prospective investigation.
Source: ConclusionsAuthors’ abstract
Background
Vitamin D deficiency has been widely reported worldwide. Vitamin D is essential for mineral homeostasis and skeletal health, and is also associated with numerous extra-skeletal diseases, including cancer, autoimmune diseases, psychosis, allergies and cardiovascular disease. Recent evidence suggests that vitamin D deficiency might be a risk factor for immunoglobulin resistance in Kawasaki disease (KD), and that levels of 25-hydroxyvitamin D3 (25(OH)D3) could predict the risk of coronary artery disease in KD patients. These findings have sparked growing interest in exploring the mechanistic and clinical links between vitamin D and KD pathogenesis.
However, the relationship between vitamin D levels and KD remains incompletely understood, warranting further comprehensive investigation.
Mechanisms and evidence reviewed
Previous studies found that proinflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-6, are elevated during the acute phase of KD and are associated with activation of vascular endothelial cells, which can lead to varying degrees of vascular wall inflammation. Vitamin D, a multifunctional prohormone with well-documented anti-inflammatory properties, may exert protective effects in KD by enhancing endothelial function, reducing coronary artery damage risk, and inhibiting platelet activity to alleviate fibrinolysis, thrombosis, and inflammation.
Conclusions
This study updates the current understanding of the association between serum vitamin D levels and KD, explores potential regulatory mechanisms underlying this relationship, and identifies critical knowledge gaps to guide future cohort studies and clinical trials in KD research. Early clinical data indicate that adjunctive vitamin D may modulate inflammatory responses in acute KD, but whether supplementation reduces intravenous immunoglobulin (IVIG) resistance or prevents coronary artery lesions remains unproven and requires prospective investigation.
Publication and source details
Original title: Vitamin D and Kawasaki disease
Dan-Dan Yang; Yuan-Yuan Zeng
Frontiers in Pharmacology · 2026
* Correspondence: Yuan-Yuan Zeng, zengyuanyuannj@126.com Copyright © 2026 Yang and Zeng.2026Yang and Zenghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-09T20:31:14.804755+00:00
DOI: 10.3389/fphar.2026.1851161 · PMC13269355